Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02733250
Title Pembrolizumab With Nab-Paclitaxel in Non-Small Cell Lung Cancer (URCOH-PMS-001)
Acronym URCOH-PMS-001
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Centre hospitalier de l'Université de Montréal (CHUM)
Indications
Therapies
Age Groups: adult
Covered Countries CAN

Facility Status City State Zip Country Details
Centre hospitalier de l'université de Montréal (CHUM) Montreal Quebec H2X 3E4 Canada Details
Jewish General Hospital Montreal Quebec H3T 1E2 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field